Initial treatment with a single capsule containing half-dose quadruple therapy versus standard-dose dual therapy in hypertensive patients (QUADUAL): statistical analysis plan for a randomized, blinded, crossover trial.
Journal Information
Full Title: Trials
Abbreviation: Trials
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateThe study has been approved by the Institutional Review Board of the Third Xiangya Hospital of Central South University (R22023). All patients can voluntarily participate in and withdraw from the study. The purpose and method of the study will be informed in detail and the informed consent will be obtained. All investigators ensure the confidentiality of patient data. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."
"Funding The study was supported by the Key Research and Development Program of Hunan Province (NO.2022SK2029) and the National Natural Science Foundation of China Projects (NO.81800271)."
"Trial registration ClinicalTrials.gov, NCT05377203. Registered May 11, 2022, https://clinicaltrials.gov/study/NCT05377203."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025